The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Steven D. Gore

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Baltimore

MD 21231

USA

[email]@jhmi.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD 21231, USA. 2006 - 2011
  • Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Cancer Research Building 288, 1650 Orleans Street, USA. 2004

References

  1. New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndrome. Gore, S.D. Hematology. Am. Soc. Hematol. Educ. Program (2011) [Pubmed]
  2. Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. Gore, S.D., Gojo, I., Sekeres, M.A., Morris, L., Devetten, M., Jamieson, K., Redner, R.L., Arceci, R., Owoeye, I., Dauses, T., Schachter-Tokarz, E., Gallagher, R.E. J. Clin. Oncol. (2010) [Pubmed]
  3. Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes. Gore, S.D., Hermes-DeSantis, E.R. Cancer. Control (2009) [Pubmed]
  4. In vitro basis for treatment with hypomethylating agents and histone deacetylase inhibitors: can epigenetic changes be used to monitor treatment? Gore, S.D. Leuk. Res. (2009) [Pubmed]
  5. Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches. Gore, S.D., Hermes-DeSantis, E.R. Cancer. Control (2008) [Pubmed]
  6. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Gore, S.D., Baylin, S., Sugar, E., Carraway, H., Miller, C.B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J.E., Rudek, M.A., Zhao, M., Smith, B.D., Manning, J., Jiemjit, A., Dover, G., Mays, A., Zwiebel, J., Murgo, A., Weng, L.J., Herman, J.G. Cancer Res. (2006) [Pubmed]
  7. Inhibitors of signaling in myelodysplastic syndrome. Gore, S.D. Best. Pract. Res. Clin. Haematol (2004) [Pubmed]
 
WikiGenes - Universities